- Home
- GL vs ICLR Comparison
GL vs ICLR Comparison
Compare GL & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GL
- ICLR
- Stock Information
- Founded
- GL 1900
- ICLR 1990
- Country
- GL United States
- ICLR Ireland
- Employees
- GL N/A
- ICLR N/A
- Industry
- GL Life Insurance
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- GL Finance
- ICLR Health Care
- Exchange
- GL Nasdaq
- ICLR Nasdaq
- Market Cap
- GL 10.2B
- ICLR 11.5B
- IPO Year
- GL N/A
- ICLR 1998
- Fundamental
- Price
- GL $121.99
- ICLR $133.96
- Analyst Decision
- GL Buy
- ICLR Buy
- Analyst Count
- GL 11
- ICLR 12
- Target Price
- GL $137.00
- ICLR $206.64
- AVG Volume (30 Days)
- GL 641.1K
- ICLR 2.1M
- Earning Date
- GL 04-30-2025
- ICLR 04-30-2025
- Dividend Yield
- GL 0.89%
- ICLR N/A
- EPS Growth
- GL 17.62
- ICLR 11.53
- EPS
- GL 12.31
- ICLR 9.19
- Revenue
- GL $5,842,352,000.00
- ICLR $8,192,621,999.00
- Revenue This Year
- GL $5.05
- ICLR $1.63
- Revenue Next Year
- GL $5.09
- ICLR $4.82
- P/E Ratio
- GL $9.89
- ICLR $15.07
- Revenue Growth
- GL 5.41
- ICLR N/A
- 52 Week Low
- GL $76.55
- ICLR $133.28
- 52 Week High
- GL $133.76
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- GL 49.57
- ICLR 33.96
- Support Level
- GL $120.60
- ICLR $135.00
- Resistance Level
- GL $122.87
- ICLR $141.96
- Average True Range (ATR)
- GL 3.27
- ICLR 6.69
- MACD
- GL 0.10
- ICLR 0.43
- Stochastic Oscillator
- GL 72.98
- ICLR 3.63
About GL Globe Life Inc.
Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.